Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Medicare policy slows Epogen sales

Aug. 6, 1997

Knoll reaches settlement on Synthroid class action lawsuit

Aug. 6, 1997

GnRH antagonists in the pipeline at Merck & Co.

Aug. 6, 1997

New direction in NOS research: Potential application in gene therapy of impotence

Aug. 5, 1997

Lilly creates new business unit dedicated to women's health

Aug. 5, 1997

Tonalin CLA reduces body fat

Aug. 5, 1997

Rezulin receives FDA marketing clearance for type 2 diabetes

Aug. 5, 1997

Sibutramine: New hope for obese patients

Aug. 5, 1997

Bioniche to manufacture Orphan Medical's Intrachol

Aug. 5, 1997

U.S. patent issues for bone substitute technology

Aug. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...